Evidence map›Paper›PMID 29879653›Full record

ArticleBiomaterials2018

A "top-down" approach to actuate poly(amine-co-ester) terpolymers for potent and safe mRNA delivery.

Yuhang Jiang, Alice Gaudin, Junwei Zhang, Tushar Agarwal, Eric Song, Amy C Kauffman, Gregory T Tietjen, Yongheng Wang, Zhaozhong Jiang, Christopher J Cheng and 1 more

Abstract read
In one paragraph

Article in Biomaterials, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Sonogenetics in the Treatment of Chronic Diseases: A New Method for Cell Regulation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. mRNA Delivery: Challenges and Advances through Polymeric Soft Nanoparticles.International journal of molecular sciences · 2024
    Review
  14. Review
  15. Review
  16. Review
  17. Rational nanoparticle design: Optimization using insights from experiments and mathematical models.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yuhang JiangDepartment of Biomedical Engineering, Yale University, New Haven, CT, 06511, USA.
Alice GaudinDepartment of Biomedical Engineering, Yale University, New Haven, CT, 06511, USA.
Junwei ZhangDepartment of Chemical and Environmental Engineering, Yale University, New Haven, CT, 06511, USA.
Tushar AgarwalDepartment of Biomedical Engineering, Yale University, New Haven, CT, 06511, USA.
Eric SongDepartment of Biomedical Engineering, Yale University, New Haven, CT, 06511, USA.
Amy C KauffmanDepartment of Biomedical Engineering, Yale University, New Haven, CT, 06511, USA.
Gregory T TietjenDepartment of Biomedical Engineering, Yale University, New Haven, CT, 06511, USA.
Yongheng WangDepartment of Biomedical Engineering, Yale University, New Haven, CT, 06511, USA.
Zhaozhong JiangDepartment of Biomedical Engineering, Yale University, New Haven, CT, 06511, USA.
Christopher J ChengAlexion Pharmaceuticals Inc., New Haven, CT, 06510, USA.
W Mark SaltzmanDepartment of Biomedical Engineering, Yale University, New Haven, CT, 06511, USA; Department of Chemical and Environmental Engineering, Yale University, New Haven, CT, 06511, USA. Electronic address: mark.saltzman@yale.edu.
Yale University · USAlexion Pharmaceuticals (United States) · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
Immunity to Genital Herpes Simplex-2R01AI054359 · NIAID · YALE UNIVERSITY · PI IWASAKI, AKIKO · 2004 to 2019
$5.2M
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of GliomasR01CA149128 · NCI · YALE UNIVERSITY · PI SALTZMAN, W. MARK · 2011 to 2020
$3.5M
Yale Interdisciplinary Bioengineering Training Grant for Diabetes ResearchT32DK101019 · NIDDK · YALE UNIVERSITY · PI SALTZMAN, W. MARK · 2013 to 2017
$1.5M
Targeted nanoparticle delivery of PNA anti-miRs to quiesce inflamed endotheliumF32HL131270 · NHLBI · YALE UNIVERSITY · PI TIETJEN, GREGORY T · 2016 to 2017
$59k
NCI NIH HHS R01 CA149128NHLBI NIH HHS F32 HL131270NIAID NIH HHS R01 AI054359NIDDK NIH HHS T32 DK101019NIGMS NIH HHS T32 GM007205
6 · The paper itself

Abstract

Gene delivery is known to be a complicated multi-step biological process. It has been observed that subtle differences in the structure and properties of polymeric materials used for gene delivery can lead to dramatic differences in transfection efficiency. Therefore, screening of properties is pivotal to optimizing the polymer. So far, most polymeric materials are built in a "bottom-up" manner, i.e. synthesized from monomers that allow modification of polymer composition or structural factors. With this method, we previously synthesized and screened a library of biodegradable poly(amine-co-ester) (PACE) terpolymers for optimized DNA delivery. However, it can be tedious and time consuming to synthesize a polymer library for screening, particularly when small changes of a factor need to be tested, when multiple factors are involved, and when the effects of different factors are synergistic. In the present work, we evaluate the potential of PACE to deliver mRNA. After observing that mRNA transfection efficiency was highly dependent on both end group composition and molecular weight (MW) of PACE in a synergistic manner, we developed a "top-down" process we called actuation, to simultaneously vary these two factors. Some of the actuated PACE (aPACE) materials presented superior mRNA delivery properties compared to regular PACE, with up to a 10

Indexed as

AnimalsCell LineCell SurvivalErythropoietinFemaleGene Transfer TechniquesHumansHydrolysisHydrophobic and Hydrophilic InteractionsMice, Inbred BALB CMolecular WeightNanoparticlesPolyaminesPolyestersPolymerizationRNA, MessengerErythropoietinPolyaminesPolyestersRNA, MessengerSmall Molecule LibrariesErythropoitinGene deliverymRNANanoparticlePoly(amine-co-ester)Polyplex

Identifiers

PMID29879653
PMCPMC6038928
OpenAlexW2804073175

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.